Lyka Labs Balance Sheet Health
Financial Health criteria checks 6/6
Lyka Labs has a total shareholder equity of ₹986.9M and total debt of ₹335.0M, which brings its debt-to-equity ratio to 33.9%. Its total assets and total liabilities are ₹1.7B and ₹695.6M respectively. Lyka Labs's EBIT is ₹83.6M making its interest coverage ratio 3.4. It has cash and short-term investments of ₹11.3M.
Key information
33.9%
Debt to equity ratio
₹335.00m
Debt
| Interest coverage ratio | 3.4x |
| Cash | ₹11.29m |
| Equity | ₹986.86m |
| Total liabilities | ₹695.63m |
| Total assets | ₹1.68b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 500259's short term assets (₹586.5M) exceed its short term liabilities (₹396.6M).
Long Term Liabilities: 500259's short term assets (₹586.5M) exceed its long term liabilities (₹299.1M).
Debt to Equity History and Analysis
Debt Level: 500259's net debt to equity ratio (32.8%) is considered satisfactory.
Reducing Debt: 500259's debt to equity ratio has reduced from 232.8% to 33.9% over the past 5 years.
Debt Coverage: 500259's debt is well covered by operating cash flow (32.4%).
Interest Coverage: 500259's interest payments on its debt are well covered by EBIT (3.4x coverage).